BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2008
View Archived Issues
Recent patent literature reports novel anticancer compounds
Read More
Yi-Gan San studied in dementia, tardive dyskinesia and borderline personality disorder
Read More
VaxGen and Raven terminate merger agreement
Read More
Cardiac-specific MAP kinase protects against cardiac ischemia in vitro and in vivo
Read More
Evotec and Ono sign agreement to identify compounds against a protease target
Read More
Encouraging results reported in first clinical trial of efficacy for GFT-505
Read More
Positive phase III data reported for new GnRH blocker degarelix
Read More
Avanir to raise gross proceeds of USD 40 million in a registered direct offering
Read More
MethylGene enters agreement with Otsuka for small-molecule kinase inhibitors
Read More
MPA requests additional information prior to initiation of Tripeps' ChronSeal phase II study
Read More
Thallion defers start date of phase II/III clinical trial of Shigamabs by six months
Read More
Evotec reports preliminary findings from study of EVT-101 in healthy volunteers
Read More
Seattle Genetics initiates second phase I clinical trial of SGN-35 in Hodgkin's lymphoma
Read More
New therapeutic agents for diabetic nephropathy described in recent Kowa patent
Read More
Recent Amgen and Kyowa Hakko patents disclose novel analgesic agents
Read More
IMPACT1 study demonstrates efficacy of Berinert P in hereditary angioedema
Read More
DJ-1 provides neuroprotection against oxidative stress
Read More
Effects on survival seen with EGF vaccine in non-small cell lung cancer patients
Read More
Lilly commences phase III LY-450139 trial for Alzheimer's disease
Read More
NeuroSearch initiates phase I NSD-788 study for anxiety and depression
Read More
Synosia Therapeutics commences phase II rufinamide trial for general anxiety disorder
Read More
Protectan CBLB-502 shows mitigation of hematopoietic damage post-radiation
Read More
UCB reports phase II results for CDP-791 in non-small cell lung cancer
Read More
Phase I/II trial in CF patients begins for Humaneered antibody against P. aeruginosa infections
Read More
NeoPharm enrolls first patients in phase II cancer trial of liposomal paclitaxel
Read More